363 related articles for article (PubMed ID: 25975847)
1. Basic MR relaxation mechanisms and contrast agent design.
De León-Rodríguez LM; Martins AF; Pinho MC; Rofsky NM; Sherry AD
J Magn Reson Imaging; 2015 Sep; 42(3):545-65. PubMed ID: 25975847
[TBL] [Abstract][Full Text] [Related]
2. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
3. Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent.
Ni D; Shen Z; Zhang J; Zhang C; Wu R; Liu J; Yi M; Wang J; Yao Z; Bu W; Shi J
ACS Nano; 2016 Mar; 10(3):3783-90. PubMed ID: 26910513
[TBL] [Abstract][Full Text] [Related]
4. Basic principles of MR contrast.
Nelson KL; Runge VM
Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
Santyr GE
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
Hermann P; Kotek J; Kubícek V; Lukes I
Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
[TBL] [Abstract][Full Text] [Related]
7. Neuro MR: protocols.
Mikulis DJ; Roberts TP
J Magn Reson Imaging; 2007 Oct; 26(4):838-47. PubMed ID: 17896388
[TBL] [Abstract][Full Text] [Related]
8. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
9. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents.
Terreno E; Castelli DD; Aime S
Contrast Media Mol Imaging; 2010; 5(2):78-98. PubMed ID: 20419761
[TBL] [Abstract][Full Text] [Related]
10. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
Bronen RA; Sze G
J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
[TBL] [Abstract][Full Text] [Related]
12. Theory of paramagnetic contrast agents in liposome systems.
Barsky D; Pütz B; Schulten K; Magin RL
Magn Reson Med; 1992 Mar; 24(1):1-13. PubMed ID: 1313522
[TBL] [Abstract][Full Text] [Related]
13. Spin-lock MRI with amplitude- and phase-modulated adiabatic waveforms: an MR simulation study.
Taheri S; Sood R
Magn Reson Imaging; 2006 Jan; 24(1):51-9. PubMed ID: 16410178
[TBL] [Abstract][Full Text] [Related]
14. [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents.
Aime S; Calabi L; Cavallotti C; Gianolio E; Giovenzana GB; Losi P; Maiocchi A; Palmisano G; Sisti M
Inorg Chem; 2004 Nov; 43(24):7588-90. PubMed ID: 15554621
[TBL] [Abstract][Full Text] [Related]
15. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
16. Update: safety, new applications, new MR agents.
Runge VM; Wells JW
Top Magn Reson Imaging; 1995; 7(3):181-95. PubMed ID: 7654396
[TBL] [Abstract][Full Text] [Related]
17. MRI contrast agents: current status and future perspectives.
Strijkers GJ; Mulder WJ; van Tilborg GA; Nicolay K
Anticancer Agents Med Chem; 2007 May; 7(3):291-305. PubMed ID: 17504156
[TBL] [Abstract][Full Text] [Related]
18. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
19. Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents.
Yan GP; Li Z; Xu W; Zhou CK; Yang L; Zhang Q; Li L; Liu F; Han L; Ge YX; Guo JF
Int J Pharm; 2011 Apr; 407(1-2):119-25. PubMed ID: 21272626
[TBL] [Abstract][Full Text] [Related]
20. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
